![]() |
市場調查報告書
商品編碼
1784630
歐洲抗菌手術縫線市場報告(2021-2031 年,範圍、細分、動態和競爭分析)Europe Antimicrobial Surgical Suture Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
歐洲抗菌手術縫線市場規模預計將從 2023 年的 1.1972 億美元增加到 2031 年的 2.5211 億美元。預計 2024 年至 2031 年期間該市場的複合年成長率為 9.8%。
執行摘要和歐洲抗菌手術縫合線市場分析:
歐洲抗菌手術縫線市場細分為德國、法國、英國、西班牙、義大利和歐洲其他地區。歐洲在全球抗菌手術縫線市場中佔據第二位,預計在預測期內將保持強勁成長。由於心血管手術、普通手術和骨科手術的興起,市場參與者越來越關注抗菌手術縫合線的生產,從而推動市場成長。
歐洲抗菌手術縫線市場細分分析:
有助於得出抗菌手術縫線市場分析的關鍵部分是類型、原料、應用和最終用戶。
根據類型,歐洲抗菌手術縫線市場分為三氯生抗菌縫線和氯己定抗菌縫線。 2023年,三氯生抗菌縫線佔據了較大的市場佔有率。
根據原料,歐洲抗菌手術縫線市場細分為聚乳酸910抗菌縫線、聚卡普隆25和聚乙醇酸。聚乳酸910抗菌縫合線在2023年佔據了最大的市場佔有率。
根據應用,歐洲抗菌手術縫線市場細分為心血管外科、一般外科、眼科外科、婦科外科、骨科外科、整形外科、獸醫外科、牙科外科等。心血管外科在2023年佔據了最大的市場。
根據最終用戶,歐洲抗菌手術縫線市場分為醫院、門診手術中心和其他。 2023年,醫院佔據了最大的市場。
歐洲抗菌手術縫合線市場展望
除了銳器傷外,全球其他類型的工傷或職業傷害數量也不斷增加。根據國際勞工組織的數據,每年約有230萬人遭受工傷,影響他們的健康和生活品質。慢性傷口負擔的不斷增加最終推動了對先進傷口護理管理方法的需求,以大幅減輕國家醫療系統的財務負擔。各國在治療傷口和規避相關風險方面投入了大量資金。因此,隨著慢性傷口發生率的上升,全球對抗菌手術縫線的需求也不斷增加。
此外,全球醫療機構進行的一般外科手術、心血管外科手術、骨科手術、婦科手術和癌症手術數量正在急劇增加。此外,老年人口的成長也導致了一些嚴重的健康問題(例如疝氣和白內障),這些問題需要手術作為主要治療方案。老年人易患心血管疾病、骨科疾病、代謝性疾病及神經系統疾病等。根據世界衛生組織估計,全球老齡人口可能會從 2019 年的約 10 億增加到 2050 年的約 21 億。美容手術在娛樂業的從業人員中也變得很普遍。這些手術適用於患有意外或先天畸形的患者,以及希望讓自己的外表更具吸引力的患者。因此,醫院或類似醫療機構中手術數量的激增正在推動對抗菌手術縫合線的需求。
歐洲抗菌手術縫合線市場國家洞察
按國家分類,歐洲抗菌手術縫線市場包括德國、法國、英國、義大利、西班牙和歐洲其他地區。德國在2023年佔最大佔有率。
由於手術部位感染 (SSI) 和抗生素抗藥性細菌發病率不斷上升,醫療機構對感染預防和控制措施的需求不斷成長,成為市場的主要驅動力。 Avidicare 最近在《研究文章》上發表的一項研究數據顯示,儘管法律和指南十分嚴格,但德國的手術部位感染 (SSI) 在 2008 年至 2016 年期間並未下降。基於 400 萬名患者的實際醫院報銷資料,研究期間的 SSI 總盛行率為 4.9%。研究人員得出結論,與德國醫院基於自願性醫院感染監測系統 (Krankenhaus-Infektions-Surveillance-System) 報告的 1.08% 的 SSI 發生率相比,SSI 的實際發生率被大大低估。
醫療保健專業人員日益認知到抗菌縫合線在減少手術部位感染 (SSI) 和改善患者預後的益處,這促進了這些縫合線的推廣應用。德國優惠的報銷政策和高昂的醫療支出也使醫院和診所能夠採用先進的縫合技術。德國完善的醫療保健體系和每年大量的外科手術對抗菌縫合線的需求很高。此外,嚴格的感染控制監管框架和指南也推動抗菌縫合線成為一項標準護理。德國企業持續進行研發活動,不斷推出創新抗菌縫線產品,進一步推動市場成長。
歐洲抗菌手術縫線市場公司簡介
市場上一些主要的參與者包括TI Medical;Healthium Medtech Limited;Meril Life Sciences Pvt Ltd;Unilene;強生;Futura Surgicare Pvt Ltd(Dolphin Sutures);Cencora, Inc.(AmerisourceBergen Corporation);Advanced MedTech Solutions Pvt. Ltd.;以及Internacional Farmaceutica 等。這些參與者正在採取各種策略,例如擴張、產品創新和併購,以便為消費者提供創新產品並增加市場佔有率。
歐洲抗菌手術縫合線市場研究方法:
本報告中的資料收集和分析遵循了以下方法:
二手資料研究:研究流程始於全面的二手資料研究,利用內部和外部資源收集每個市場的定性和定量資料。常用的二手資料研究來源包括但不限於:
公司網站、年度報告、財務報表、經紀商分析和投資者介紹。行業期刊及其他相關出版品。政府文件、統計資料庫和市場報告。針對在市場營運的公司的新聞文章、新聞稿和網路廣播。註:公司簡介部分所包含的所有財務資料均已標準化為美元。對於以其他貨幣報告的公司,數據已使用相應年份的相關匯率轉換為美元。
一手研究 Insight Partners 每年都會與行業利益相關者和專家進行大量的一手調查,以驗證其資料分析,並獲得寶貴的見解。這些研究訪談旨在:
驗證並完善二手資料研究的結果。提升分析團隊的專業知識和市場理解。深入了解市場規模、趨勢、成長模式、競爭動態和未來前景。一手資料研究透過電子郵件互動和電話訪談進行,涵蓋不同地區的各種市場、類別、細分市場和次細分市場。參與者通常包括:
產業利害關係人:副總裁、業務發展經理、市場情報經理和國家銷售經理外部專家:估值專家、研究分析師和具有行業專業知識的關鍵意見領袖
The Europe antimicrobial surgical suture market size is expected to reach US$ 252.11 million by 2031 from US$ 119.72 million in 2023. The market is estimated to record a CAGR of 9.8% from 2024-2031.
Executive Summary and Europe Antimicrobial Surgical Suture Market Analysis:
The Europe antimicrobial surgical suture market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Europe occupies the second position in the global antimicrobial surgical suture market and is expected to register a robust growth rate over the forecast period. The increasing focus of market players on manufacturing antimicrobial surgical sutures due to the rise in cardiovascular surgeries, general surgeries, and orthopedic surgeries is leading to market growth.
Europe Antimicrobial Surgical Suture Market Segmentation Analysis:
Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.
Based on type, the Europe antimicrobial surgical suture market is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.
By raw materials, the Europe antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.
By application, the Europe antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynaecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.
By end user, the Europe antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.
Europe Antimicrobial Surgical Suture Market Outlook
Besides sharp injuries, the number of other types of workplace or occupational injuries is increasing worldwide. According to the International Labor Organization, ~2.3 million people experience work-related injuries every year, affecting their health and quality of life. The soaring burden of chronic wounds eventually propels the demand for advanced wound care management methods to substantially reduce the financial burden from national healthcare systems. Various countries spend significant amounts of money on treating injuries and avoiding associated risks. Therefore, with the increasing incidence of chronic wounds, the demand for antimicrobial surgical sutures is also increasing worldwide.
Further, the number of general, cardiovascular, orthopedic, gynecological, and cancer surgeries performed in healthcare settings is increasing tremendously across the world. Moreover, the growing geriatric population contributes to severe health conditions (e.g., hernia and cataracts) that require surgeries as a primary treatment option. The geriatric population is prone to CVDs, orthopedic disorders, metabolic disorders, and neurological disorders, among others. According to the WHO, the aging population across the world is likely to rise from ~1 billion in 2019 to ~2.1 billion by 2050. Aesthetic surgeries have also become common among people working in the entertainment industry. These surgeries are performed on patients who have accidental or inherent deformities and on those who wish to make their appearance more appealing. Therefore, the surging number of surgeries performed in hospitals or similar healthcare institutions is driving the demand for antimicrobial surgical sutures.
Europe Antimicrobial Surgical Suture Market Country Insights
Based on country, the Europe antimicrobial surgical suture market comprises Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2023.
The increasing demand for infection prevention and control measures in healthcare settings is a primary market driver, owing to the rising incidence of surgical site infections (SSIs) and antibiotic-resistant bacteria. Data from a recent study published in Research Article by Avidicare indicate that despite stringent laws and guidelines, surgical site infections (SSIs) in Germany did not decline between 2008 and 2016. Based on real hospital reimbursement data from 4 million patients, the study period's total SSI prevalence was 4.9%. The researchers conclude that the actual number of SSIs has been greatly underestimated compared to the self-reported 1.08% SSI rates for German hospitals based on the voluntary Krankenhaus-Infektions-Surveillance-System.
The growing awareness among healthcare professionals about the benefits of antimicrobial sutures in reducing SSIs and improving patient outcomes is contributing to the adoption of these sutures. Favorable reimbursement policies and high healthcare expenditure in Germany also enable hospitals and clinics to adopt advanced suturing technologies. The country's well-established healthcare system and many annual surgical procedures create a high demand for antimicrobial sutures. Furthermore, stringent regulatory frameworks and guidelines for infection control are driving the adoption of antimicrobial sutures as a standard of care. Ongoing research and development activities by companies in the country are leading to the introduction of innovative antimicrobial suture products, further fueling market growth.
Europe Antimicrobial Surgical Suture Market Company Profiles
Some of the key players operating in the market include TI Medical; Healthium Medtech Limited; Meril Life Sciences Pvt Ltd; Unilene; Johnson & Johnson; Futura Surgicare Pvt Ltd (Dolphin Sutures); Cencora, Inc. (AmerisourceBergen Corporation); Advanced MedTech Solutions Pvt. Ltd.; and Internacional Farmaceutica SA among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
Europe Antimicrobial Surgical Suture Market Research Methodology :
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise